The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 06, 2011
Filed:
Nov. 30, 2005
Yeonjoon Kim, Yongin-si, KR;
Sun-young Kim, Seoul, KR;
Jung Sun Hwang, Yongin-si, KR;
Kyoung Min Lim, Suwon-si, KR;
Miyoung Park, Anyang-si, KR;
Hyun Ju Koh, Gunpo-si, KR;
Sa-yong Hong, Seoul, KR;
Song Seok Shin, Yongin-si, KR;
Jin Kyu Choi, Suwon-si, KR;
Joo-hyun Moh, Yongin-si, KR;
Shin Chung, Yongin-si, KR;
Byoung Young Woo, Yongin-si, KR;
Sung IL Kim, Yangju-si, KR;
Yeonjoon Kim, Yongin-si, KR;
Sun-Young Kim, Seoul, KR;
Jung Sun Hwang, Yongin-si, KR;
Kyoung Min Lim, Suwon-si, KR;
Miyoung Park, Anyang-si, KR;
Hyun Ju Koh, Gunpo-si, KR;
Sa-Yong Hong, Seoul, KR;
Song Seok Shin, Yongin-si, KR;
Jin Kyu Choi, Suwon-si, KR;
Joo-Hyun Moh, Yongin-si, KR;
Shin Chung, Yongin-si, KR;
Byoung Young Woo, Yongin-si, KR;
Sung Il Kim, Yangju-si, KR;
Amorepacific Corporation, Seoul, KR;
Abstract
2-cyclopenten-1-one oxime derivatives represented by Formula (I), or pharmaceutically acceptable salts thereof inhibit the production of TNF-α or PDE4, and therefore show therapeutic effect in inflammatory or immunological disorders mediated through TNF-α or PDE4.